ABSTRACT
El cáncer de ovario, es una patología de diagnóstico tardío y de alta mortalidad en sus estadios avanzados. Se presenta el caso de una paciente de 51 años, portadora de un cáncer de ovario (Cistoadenocarcinoma seroso papilar ovárico bilateral) estadio IIIb, con 13 años de sobrevida post tratamiento. Se analiza tanto su historia clínica, estudio, tratamiento y su evolución en el tiempo
Subject(s)
Humans , Female , Middle Aged , Adenocarcinoma, Papillary/diagnosis , Ovarian Neoplasms/diagnosis , Adenocarcinoma, Papillary/drug therapy , Adenocarcinoma, Papillary/pathology , Disease-Free Survival , Neoplasm Metastasis/diagnosis , Ovarian Neoplasms/drug therapy , Ovarian Neoplasms/pathology , Peritoneal Neoplasms/secondaryABSTRACT
A case of patient developing epithelial ovarian cancer 15 years after carcinoma of cervix treated successfully with radiotherapy, is reported. The patient has shown good initial response to chemotherapy and surgery.
Subject(s)
Adenocarcinoma, Papillary/drug therapy , Adult , Female , Humans , Ovarian Neoplasms/drug therapy , Peutz-Jeghers Syndrome/complications , Time Factors , Uterine Cervical Neoplasms/drug therapyABSTRACT
Forty patients of advanced ovarian carcinoma were treated with monthly cycles of cyclophosphamide, adriamycin and cisplatin. Debulking surgery was done in 29 cases. Clinical complete response was seen in 70 percent and an overall response in 85 percent of cases. The median follow-up was 30 months. The actuarial overall survival was 45 percent and the disease free survival was 35 percent at 3 years. The present protocol appears to have an important influence on initial control of disease but relapses continue to occur following the treatment. Cytoreductive surgery before or after three cycles of chemotherapy has a favourable influence on disease free survival (DFS). Prolonged follow up will be necessary to determine the overall influence on long term survival.